Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn | -310.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -310.15% |
| Dec 31, 2025 | -106.95% |
| Sep 30, 2025 | 56.61% |
| Jun 30, 2025 | -144.07% |
| Mar 31, 2025 | 2,874.75% |
| Dec 31, 2024 | 167.56% |
| Sep 30, 2024 | -346.88% |
| Jun 30, 2024 | 305.89% |
| Mar 31, 2024 | 146.59% |
| Dec 31, 2023 | 149.79% |
| Sep 30, 2023 | 91.61% |
| Jun 30, 2023 | -61.74% |
| Mar 31, 2023 | 92.73% |
| Dec 31, 2022 | 64.82% |
| Sep 30, 2022 | -149.01% |
| Jun 30, 2022 | -107.93% |
| Mar 31, 2022 | -325.47% |
| Dec 31, 2021 | -249.72% |
| Sep 30, 2021 | 18,436.01% |
| Jun 30, 2021 | 210.50% |